Latest by Canadian AIDS Treatment Information Exchange
There are several emerging treatments for hepatitis C virus. Here is a brief guide to some drugs and the classes to which they belong.
In late June 2017, Health Canada licensed the sale and use of a new formulation of the anti-HIV drug raltegravir (Isentress) as part of the treatment of HIV.
Researchers in San Diego, Calif., said that having both "mental health and substance diagnoses" was not a barrier to successful HCV treatment.
For homeless people who may be reluctant to engage with hospital-based services, researchers in Brighton, England established a liver monitoring and care service located in the community that focused on people 40 years and older.
Researchers conducted a study to assess the impact of direct-acting antivirals on issues such as mood and factors affected by mood, such as physical activity and fatigue.
Researchers found that people who were cured of hepatitis C virus underwent "significant improvement" in blood sugar levels and in many cases participants' doctors were able to reduce the dose of medicines used to help control blood sugar.
Researchers found that HIV-positive Indigenous people who were prescribed antiretroviral therapy continued to have elevated rates of death compared to non-Indigenous people.
A doctor, a pharmacist and a person who juggles multiple conditions reflect on the challenges and offer their best advice.
In the past decade, there have been tremendous advances in HIV research, arguably more so than for any other infectious disease. Here's a quick tour through some of the most influential findings of the past 10 years.
"The new screening guidelines ignore expert advice regarding who should be tested for hep C, setting a dangerous public health policy where dollars come first and the health of Canadians comes last."